SHP Wealth Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.7K Hold
20
– – ﹤0.01% 1443
2026
Q2
$1.7K Buy
20
+9
+82% +$646 ﹤0.01% 1443
2026
Q1
$725 Buy
+11
New +$699 ﹤0.01% 1547

Other funds holding CYTK

SHP Wealth Management's CYTK Position: Q3 2026 in Review

SHP Wealth Management held its Cytokinetics (CYTK) position steady in Q3 2026 at 20 shares worth $1.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1443.

SHP Wealth Management first reported a position in CYTK in Q1 2026 and has held it in 3 quarters since. 473 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • SHP Wealth Management held 20 shares of Cytokinetics worth $1.7K as of Q3 2026.
  • SHP Wealth Management left its Cytokinetics share count unchanged in Q3 2026.
  • Cytokinetics made up ﹤0.01% of SHP Wealth Management's portfolio in Q3 2026, its #1443 holding.
  • SHP Wealth Management first reported a position in Cytokinetics in Q1 2026 and has held it in 3 quarters since.
  • 473 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on SHP Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.